Skip to main content

Cancer Biomarkers Market Overview and Forecast Analysis up to 2025

Increasing incidences of various types of cancers all over the globe has caused a rise in the need for cancer biomarkers, thereby providing a healthy impetus to the associated market. Such an increase in this deadly ailment is also due a surge in habits such as smoking and drinking, as well as exposure to high amounts of particulate matter and pollution. With widespread advancements expected to occur in terms of new and efficient equipment used to monitor cancer cases, the global cancer biomarker market too is prophesized to witness an unprecedented progress.
According expert analysts, the global cancer biomarkers market is expected to exhibit a splendid CAGR of 11.8% during the forecast period from 2017 to 2025. In this timeframe, the market is anticipated to gain revenue worth US$27.63 bn by the end of 2025, which is a decent rise from the earlier revenue worth of US$10.25 bn in 2016.
CTC Tests Hold Leading Position as Key Revenue Generating Segment
The global cancer biomarker market is mainly segregated under few categories such as test type, disease indication, and regional analyses. With respect to test type, PSA tests, CTC tests, AFP tests
CA tests, HER2 tests, BRCA tests, ALK tests, CEA tests, EGFR mutation tests, KRAS mutation tests, and others are segments. Under disease indication, breast cancer, lung cancer, colorectal cancer, melanoma, blood cancer, prostate cancer, ovarian cancer, stomach cancer, liver cancer, and others, comprise major segments in eh global cancer biomarkers market.
With respect to the test type, the CTC tests segment accounted for maximum share in the global cancer markers market in 2016. This segment is furthermore expected to continue its leading stance during the forecast period from 2017 to 2025. The main factors responsible for ushering positive growth in the market involve an increase in prevalence of various types of tumors and rising incidences of cancers related to the vital organs. CTC tests also are possess fast processing abilities and provide quality results than other tests, thus being highly preferred by healthcare specialists.
From the perspective of disease indication, the lung cancer segment held topmost market shares in the global cancer biomarkers market in 2016. This segment is further expected to proliferate during the forecast period as a result of several factors. Increasing prevalence of lung cancer in most regions, rising instances of cigarette smoking among the global population, and increasing geriatric population are some of the reasons that are responsible for causing lung cancer on a large scale basis. In addition, several technological advancements are occurring with regards to decreasing side-effects associated with biomarkers tests and early detection of the illness. These advancement too are driving an extensive demand for lung cancer diagnosis from a global perspective.
North America Remain Triumphant Owing to High Presence of Cancers
From a geographical perspective, the global cancer biomarker market is spread across Asia Pacific, Europe, the Middle East and Africa, Latin America, and North America. Of these, North America remains dominant since 2016, owing to several reasons. Some of the key factors include high prevalence of different cancer types, increasing healthcare expenditure leading to a rise in demand for better diagnostic tests and health care services, and widespread technological advancements in the field of cancer biomarkers occurring in the region. However, the market in Asia Pacific is projected to register a significant growth rate by 2025 due to availability of a large patient pool and increasing awareness about deadly healthcare concerns such as cancer. In addition, high percentage of geriatric population, and increasing disposable incomes are expected to propel the market in this region too.
Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Agilent Technologies, QIAGEN, Merck & Co., Inc., Hologic, Inc., Novartis AG, bioMérieux SA, and Genomic Health, Inc., are key players operating in the global cancer biomarkers market.

Comments

Post a Comment

Popular posts from this blog

Angioplasty Balloons & Stents Market Research Report | Forecast Until 2027

Complications with Existing Treatments to Drive Innovations The healthcare sector is no stranger to innovations and technological advancements. Research and development activities continue to improve the efficacy of treatments and bring forward new therapies to treat a range of diseases. Over the past couple of decades, minimally invasive procedures have gained a great amount of popularity within the healthcare sector. A similar trend can be observed within the angioplasty balloons & stents market as the adoption of minimally invasive procedures is on the rise, particularly among patients who have been diagnosed with coronary heart diseases or experienced a heart attack. Request Sample Of Report –   https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5627 At present, healthcare experts are focusing on minimizing the complications involved with the percutaneous coronary intervention (PCI) by leveraging the benefits of technology that conti...
Post a Comment
Read more

Autoimmune Disease Diagnostics Market Analysis and Forecast up to 2023

Autoimmune Disease Diagnostics Market – Snapshot When immune system attacks the body mistakenly, then the resulting condition is known as autoimmune disease. Some of the autoimmune diseases are found more commonly in certain ethnicities than others. A case in point is high prevalence of lupus amongst the Hispanic and African-American group of people rather than Caucasians. The global autoimmune disease diagnostics market is estimated to make substantial gains due to rising incidences of autoimmune diseases across the globe. Request Sample Of Report –    https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351 Some of the autoimmune diseases such as lupus and multiple sclerosis run within families. In that case, the family members will inherit vulnerability to the autoimmune illness that runs in the family but might not necessarily be affected by it. Increased Prevalence of Autoimmune Diseases to Spell Growth of the Market Many of the auto...
Post a Comment
Read more

Analysis of COVID-19 Collagen Peptide and Gelatin Market

Collagen Peptide and Gelatin Market: Overview According to Transparency Market Research’s latest report on the global collagen peptide and gelatin market for the historical period  2017–2018  and forecast period  2019–2027 , increase in commercialization of novel collagen-based drug delivery systems and rise in social awareness about personal well-being are projected to drive the global collagen peptide and gelatin market According to the report, the global collagen peptide and gelatin market was valued at  US$ 5,976.9 Mn  in  2018  and is projected to expand at a CAGR of  8.7%  from  2019  to  2027 To know the scope of our report  Get a Sample  on Collagen Peptide and Gelatin Market Increase in social awareness about personal well-being and rigorous research and development activities in regenerative medicine and wound healing: Key Drivers Major factors driving the collagen peptide application in nutrac...
Post a Comment
Read more